[go: up one dir, main page]

LU76706A1 - - Google Patents

Info

Publication number
LU76706A1
LU76706A1 LU76706A LU76706A LU76706A1 LU 76706 A1 LU76706 A1 LU 76706A1 LU 76706 A LU76706 A LU 76706A LU 76706 A LU76706 A LU 76706A LU 76706 A1 LU76706 A1 LU 76706A1
Authority
LU
Luxembourg
Application number
LU76706A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU76706A1 publication Critical patent/LU76706A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
LU76706A 1976-02-07 1977-02-04 LU76706A1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762604845 DE2604845A1 (de) 1976-02-07 1976-02-07 Neue piperazinderivate

Publications (1)

Publication Number Publication Date
LU76706A1 true LU76706A1 (xx) 1977-06-28

Family

ID=5969327

Family Applications (1)

Application Number Title Priority Date Filing Date
LU76706A LU76706A1 (xx) 1976-02-07 1977-02-04

Country Status (25)

Country Link
US (1) US4079137A (xx)
JP (1) JPS52105186A (xx)
AT (1) AT355578B (xx)
AU (1) AU504526B2 (xx)
BE (1) BE850492A (xx)
CA (1) CA1094560A (xx)
CH (1) CH631448A5 (xx)
CS (1) CS201544B2 (xx)
DD (1) DD128133A5 (xx)
DE (1) DE2604845A1 (xx)
DK (1) DK138891C (xx)
ES (1) ES455691A1 (xx)
FI (1) FI63226C (xx)
FR (1) FR2340311A1 (xx)
GB (1) GB1550545A (xx)
HU (1) HU173483B (xx)
IE (1) IE44339B1 (xx)
IL (1) IL51316A (xx)
LU (1) LU76706A1 (xx)
NL (1) NL7700841A (xx)
NO (1) NO142625C (xx)
PL (1) PL105526B1 (xx)
PT (1) PT66154B (xx)
SE (1) SE7701187L (xx)
ZA (1) ZA77248B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
US4483988A (en) * 1980-03-14 1984-11-20 Richardson Merrell Inc. Substituted derivatives of 4-t-alkoxycarbonyl-piperazin-2-ones
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
KR20070086663A (ko) 2004-12-06 2007-08-27 사이클론 파아머슈티컬 인코오퍼레이티드 암 백신 보조제로서 알파 티모신 펩티드류
US20080300166A1 (en) * 2007-06-01 2008-12-04 Sciclone Pharmaceuticals, Inc. Treatment of Melanoma with Alpha Thymosin Peptides
EP2240195A4 (en) * 2007-12-12 2011-12-21 Sciclone Pharmaceuticals Inc TREATMENT OF MELANOMA WITH ALPHA-THYMOSIN PEPTIDES IN ASSOCIATION WITH ANTIBODIES AGAINST ANTIGEN 4 ASSOCIATED WITH CYTOTOXIC LYMPHOCYTE T (CTLA4)
WO2009076587A1 (en) * 2007-12-13 2009-06-18 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with a kinase inhibitor
EP2230908A1 (en) * 2007-12-14 2010-09-29 Sciclone Pharmaceuticals, Inc. Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa)
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
CN102458470B (zh) * 2009-05-08 2016-01-20 赛生制药有限公司 作为疫苗增强剂的α胸腺素肽
BR112017007817A2 (pt) 2014-10-21 2017-12-19 Sciclone Pharmaceuticals Inc tratamento do câncer com estimuladores imunológicos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472856A (en) * 1967-05-29 1969-10-14 Sterling Drug Inc 1-((thianaphthenyl)-lower-alkyl)-4-substituted-piperazines
US4031216A (en) * 1974-08-12 1977-06-21 Knoll A.G. Chemische Fabriken 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines
DE2438725A1 (de) * 1974-08-12 1976-02-26 Knoll Ag Piperazinderivate

Also Published As

Publication number Publication date
FI63226C (fi) 1983-05-10
PT66154A (fr) 1977-03-01
DK138891C (da) 1979-04-23
AU504526B2 (en) 1979-10-18
ES455691A1 (es) 1978-01-01
FR2340311A1 (fr) 1977-09-02
AT355578B (de) 1980-03-10
CA1094560A (en) 1981-01-27
SE7701187L (sv) 1977-08-08
BE850492A (fr) 1977-07-18
DK49077A (da) 1977-08-08
ATA68177A (de) 1979-08-15
NO142625C (no) 1980-09-17
CH631448A5 (de) 1982-08-13
CS201544B2 (en) 1980-11-28
FI770398A7 (xx) 1977-08-08
FI63226B (fi) 1983-01-31
HU173483B (hu) 1979-05-28
IL51316A0 (en) 1977-03-31
PL105526B1 (pl) 1979-10-31
US4079137A (en) 1978-03-14
DD128133A5 (de) 1977-11-02
JPS52105186A (en) 1977-09-03
GB1550545A (en) 1979-08-15
NO142625B (no) 1980-06-09
IL51316A (en) 1980-12-31
IE44339L (en) 1977-08-07
ZA77248B (en) 1977-11-30
FR2340311B1 (xx) 1980-02-08
DK138891B (da) 1978-11-13
NO770374L (no) 1977-08-09
PT66154B (fr) 1978-07-07
DE2604845A1 (de) 1977-08-18
AU2195277A (en) 1978-08-10
NL7700841A (nl) 1977-08-09
IE44339B1 (en) 1981-10-21

Similar Documents

Publication Publication Date Title
FR2347676B1 (xx)
FR2340311B1 (xx)
FR2340319B1 (xx)
JPS5340933U (xx)
JPS5636627Y2 (xx)
JPS5648990Y2 (xx)
JPS558099B2 (xx)
JPS571738B2 (xx)
JPS5363357U (xx)
JPS52106636U (xx)
JPS5345343B2 (xx)
JPS571449B2 (xx)
JPS52119659U (xx)
JPS52151339U (xx)
JPS5390946U (xx)
CS175515B1 (xx)
JPS5335596U (xx)
JPS52147857U (xx)
CS178499B1 (xx)
JPS52107257U (xx)
JPS5368408U (xx)
JPS52101689U (xx)
CH600358A5 (xx)
CH600205A5 (xx)
BG23411A1 (xx)